Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
1.560
-0.020 (-1.27%)
At close: May 19, 2025, 4:00 PM
1.600
+0.040 (2.56%)
After-hours: May 19, 2025, 7:11 PM EDT
Cellectis Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Cellectis stock ranges from a low of $4.00 to a high of $10. The average analyst price target of $6.67 forecasts a 327.56% increase in the stock price over the next year.
Price Target: $6.67 (+327.56%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cellectis stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +156.41% | May 13, 2025 |
Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +220.51% | Nov 5, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +541.03% | Jun 12, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +284.62% | May 31, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +284.62% | Nov 1, 2023 |
Financial Forecast
Revenue This Year
73.10M
from 49.22M
Increased by 48.52%
Revenue Next Year
76.87M
from 73.10M
Increased by 5.17%
EPS This Year
-1.17
from -0.41
EPS Next Year
-0.87
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 150.1M | 139.6M | 65.1M | ||
Avg | 73.1M | 76.9M | 63.9M | ||
Low | 29.4M | 29.4M | 60.8M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 204.9% | 90.9% | -15.3% | ||
Avg | 48.5% | 5.2% | -16.9% | ||
Low | -40.3% | -59.8% | -21.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.80 | -0.30 | -1.92 |
Avg | -1.17 | -0.87 | -1.88 |
Low | -1.46 | -1.59 | -1.79 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.